That is possible, but my opinion differs. I don
Post# of 148274
I don’t believe for a second that the company or RP would intentionally delay such an important trial purely based on a deal or only to impact the share price (not only for the current or future patients sake).
I believe that NP over-promised the “any day now” and then there were delays due to something else.....trying to get the trial perfectly correct the first time, missed data points/meetings as a result of license discussions where RP missed a FDA or trial deadline or something, or simply the trial changed and caused an unexpected delay, etc.
Regardless the reason for the delay, let’s hope for some big news next week for both mono pivotal trial and TNBC injection.